You are viewing the site in preview mode
Skip to main content
| |
n = 67
|
|---|
|
Sites and types of infections, n (%)
|
|
- Respiratory tract
|
30 (45%)
|
|
- Herpes zoster
|
16 (24%)
|
|
- Gastrointestinal tract
|
6 (9%)
|
|
- Bacteremia
|
6 (9%)
|
|
- Urinary tract
|
6 (9%)
|
|
- ABSSI
|
2 (3%)
|
|
- Other
|
1 (2%)
|
|
Type of treatment at infection, n (%)
|
|
- Induction
|
29 (43%)
|
|
- Maintenance
|
36 (54%)
|
|
- No treatment
|
2 (3%)
|
|
Prednisone dose at the time of infection, median (range)
|
19 (5–30) mg/day
|
- ABSSI acute bacterial skin and skin structure infections, mg milligrams
